CPHA Canvax

"This webinar informs health care providers on COVID-19 in children and authorized COVID-19 vaccine for pediatric use in Canada.

At the end of this webinar, participants will be able to:

  • Identify the factors that parents or guardians should consider when deciding on COVID-19 vaccination for children aged 5-11 years.
  • Describe the COVID-19 pandemic among children 5-11 years of age in Canada.
  • Summarize the clinical trial information available on the COVID-19 vaccine authorized in children 5-11 years of age.
  • Explain NACI recommendations for children 5-11 years of age. " - Public Health Agency of Canada 
Rating See Comments Ratings


Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Specific Populations,Children Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Program Planning and Delivery
Program Delivery and Evaluation
Monitoring and Surveillance
Outbreaks and Pandemics
Specific Populations


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.